British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).
about
Routine viral load monitoring versus standard care for reducing morbidity and mortality in adolescent and adult patients living with HIV on antiretroviral therapy (ART)Therapeutic drug monitoring of antiretrovirals for people with HIVCD4 immunophenotyping in HIV infection.When should children with HIV infection be started on antiretroviral therapy?Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapyA cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trialNevirapine once daily: pharmacology, metabolic profile and efficacy data of the new extended-release formulation.Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.Efavirenz use during pregnancy and for women of child-bearing potentialPharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation.Cost-effectiveness analysis of initial HIV treatment under Italian guidelines.Label free detection of CD4+ and CD8+ T cells using the optofluidic ring resonator.Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitorUse of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda.Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine.Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.Molecular assays for monitoring HIV infection and antiretroviral therapy.Fosamprenavir calcium plus ritonavir for HIV infection.HIVDrug interactions in the management of HIV infection: an update.High treatment success rates when switching to once daily nevirapine containing antiretroviral therapyAre literature references sufficient for dose recommendations? An FDA case study of efavirenz and rifampin.The genitourinary complications of HIV infection in men.HIV in prisons: the London experience.Prevention of atherosclerosis in patients living with HIV.Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.Atazanavir: its role in HIV treatmentLate diagnosis of HIV in Europe: definitional and public health challenges.Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection.The impact of disease stage on direct medical costs of HIV management: a review of the international literature.Role of darunavir in the management of HIV infection.Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK.
P2860
Q24203980-755F751C-9494-41F1-90D3-B7AC2D8A5760Q24239932-4411F917-F029-4E61-82F2-3F069A0CEE24Q30372724-5A681FFE-A23B-442A-BE34-E3C5EF5619F0Q33325580-8D73969D-CF44-4F04-93BB-3678872004D0Q33378828-D7DDB357-0588-4239-A3D5-1B238CCA7883Q33543151-FDB6512F-E5AA-4F7C-A9B5-B1BAE093A11FQ33578024-D0366BC4-A780-49C5-88B0-ED750E4EEB0DQ33765130-75BE3265-EC79-4C75-9EC8-1DAE76C79D6FQ33850152-8B35AE7C-844C-4F27-B509-3F08EC3AA877Q34174009-2BAB6ED4-BA70-4F7F-9CC9-DE08DE196278Q34405742-12C1CC10-6D12-4698-810A-73E439818CC5Q34632385-9EF08A6E-0180-4243-9C8D-04054691722DQ35191614-DA633B09-6B85-4ED5-9977-75CDB60823E2Q35602604-955AC618-1413-4867-A2AB-A7CBAAEFD64FQ35638894-27F8A1AA-F691-4816-B74D-259712DF5746Q36018893-B3D4929D-5903-4407-9777-1D25460C41D0Q36537900-C832E731-13F5-4E21-9149-F32694B4129CQ36621432-7FF46947-9053-492A-8F8A-CA79C3CC31D8Q36628549-60C55192-5DDC-4FAD-8094-E66F009E87BDQ36798007-908BEE78-D86A-46B9-8E9B-1FFE4A3EA9E9Q36816024-255AD24A-7D09-4AD3-931B-8FA0CD3E58B1Q36839698-BAAA5F64-2E04-4F58-9F56-A7BF6E1D3AD8Q36928794-FF3A2EFB-934E-46BB-BCBF-65E7C7E410C9Q37000733-7E714CF5-6E2D-44EF-8198-CECAB0F2923EQ37063896-0B42C2A9-C91F-4953-9ECE-5DCF470B73E7Q37095692-FE5EBB7C-6C78-489C-9979-0000DC0AFDD6Q37141961-C23C9F55-792A-4CBD-B21C-95A26B79A618Q37165017-DAE4E831-3C35-4598-A4D5-984E2280294BQ37167541-1EE49C00-BDA0-4146-BA77-A7D19A4DC331Q37206232-8CD859F9-7C9D-4E87-9635-BACF928C8BD3Q37207800-8133C14D-3F35-4E06-A722-861986C4EF6AQ37249418-698D343F-D5F3-4A2A-87F4-A7FB7F7E7972Q37334197-11E21CFD-2C09-480D-B218-B5C1128A0673Q37415603-168FC266-79CA-4297-A3E3-8866A0CCD60EQ37593100-9837CFAB-28E0-48A0-9B49-795E0F7AC397Q37643598-73179377-AEC8-49C0-843B-235D4D3AFF3DQ37823555-A2A26BAB-EC3A-4F94-B302-B5AC3E223DFDQ37823559-89BB0E39-B4E9-45EB-B886-91970F71768BQ37957871-26747319-2D63-46AB-A4C0-76A921FEEA62Q38435854-2212E285-CC56-47D5-AECA-93F16B322A3F
P2860
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@ast
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@en
type
label
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@ast
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@en
prefLabel
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@ast
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@en
P2093
P2860
P1433
P1476
British HIV Association (BHIVA ...... antiretroviral therapy (2006).
@en
P2093
A J Bernard
A M Geretti
D Churchill
P2860
P304
P356
10.1111/J.1468-1293.2006.00424.X
P577
2006-11-01T00:00:00Z